WCN26-5500 CLINICAL CHARACTERISTICS AND OUTCOMES OF PERITONEAL DIALYSIS PATIENTS WITH END-STAGE KIDNEY DISEASE DUE TO MULTIPLE MYELOMA OR AL AMYLOIDOSIS: A SINGLE-CENTER EXPERIENCE

Read full text Summarise with VIRAT
Authors: Y Inaba, Rena Sumura, Chiaki Kasahara, Tomoki Sato, Yumi Kuraguchi, Shingo Urate, Mai Yanagi, Shohei Yamada, Yoshitaka Ishibashi
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Patients with paraproteinemia-related diseases, such as multiple myeloma and AL amyloidosis, often progress rapidly to end-stage kidney disease (ESKD). Because these conditions are usually diagnosed at an advanced stage of kidney failure, many patients have limited time to choose their modality of kidney replacement therapy. Peritoneal dialysis (PD) may offer advantages such as preserving residual kidney function and providing greater flexibility in daily life. However, the effectiveness of PD in this population remains unclear.

Fields of Study & Subjects

Dialysis and Renal Disease Management Multiple Myeloma Research and Treatments Amyloidosis: Diagnosis Treatment Outcomes

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105895–105895
Publication date
25 March 2026
Language
EN